Harrow (HROW) Enterprise Value Growth (1y) (2011 - 2026)
Harrow (HROW) Enterprise Value Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Harrow | 1.53 Bn | 1.45 Bn | 50.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -58.00% |
| Mar 31, 2026 | -41.62% |
| Dec 31, 2025 | -53.95% |
| Sep 30, 2025 | -2.32% |
| Jun 30, 2025 | 25.24% |
| Mar 31, 2025 | 12.11% |
| Dec 31, 2024 | 42.73% |
| Sep 30, 2024 | 1.72% |
| Jun 30, 2024 | -137.54% |
| Mar 31, 2024 | -180.26% |
| Dec 31, 2023 | 18.68% |
| Sep 30, 2023 | -50.03% |
| Jun 30, 2023 | 42.24% |
| Mar 31, 2023 | 46.54% |
| Dec 31, 2022 | -100.32% |
| Sep 30, 2022 | 27.45% |
| Jun 30, 2022 | 39.14% |
| Mar 31, 2022 | -642.75% |
| Dec 31, 2021 | -54.10% |
| Sep 30, 2021 | -1,022.82% |